Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above
Condition: Pneumonia, Pneumococcal Intervention: Biological: 23-Valent Pneumococcal Polysaccharide Vaccine Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials